Lista de obras - Peter Hau - Dominio Público Uruguay

1H-nuclear magnetic resonance spectroscopy of glioblastoma cancer stem cells

artículo científico publicado en 2011

ACTR-20. FINDING A PREDICTIVE MARKER FOR COMPLIANCE TO TTFIELDS THERAPY – THE COMPTUNE STUDY

artículo científico publicado en 2017

ACTR-23. MOLECULAR GENETIC, HOST-DERIVED AND CLINICAL DETERMINANTS OF LONG-TERM SURVIVAL IN GLIOBLASTOMA: FIRST RESULTS FROM THE BRAIN TUMOR FUNDERS’ COLLABORATIVE CONSORTIUM

AIDS-Related Central Nervous System Toxoplasmosis With Increased 18F-Fluoroethyl-L-Tyrosine Amino Acid PET Uptake Due to LAT1/2 Expression of Inflammatory Cells.

artículo científico publicado en 2017

ANGI-06. CHARACTERISATION OF INVASION OF HUMAN BRAIN TUMOUR INITIATING CELLS IN HUMAN GLIOBLASTOMA

article by Verena Leidgens et al published 6 November 2017 in Neuro-Oncology

ATF4 contributes to autophagy and survival in sunitinib treated brain tumor initiating cells (BTICs)

article

Aberrant expression of c-Jun in glioblastoma by internal ribosome entry site (IRES)-mediated translational activation

artículo científico publicado en 2012

Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells.

artículo científico publicado en 2015

Adaptive Immune Response to and Survival Effect of Temozolomide- and Valproic Acid-induced Autophagy in Glioblastoma

artículo científico publicado en 2016

Adults with CNS primitive neuroectodermal tumors/pineoblastomas: results of multimodal treatment according to the pediatric HIT 2000 protocol

artículo científico publicado en 2014

Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas

artículo científico publicado en 2010

Advances in the therapy of high-grade glioma at relapse: pegylated liposomal doxorubicin

artículo científico publicado en 2002

Adverse event grading following CTCAE v3.0 underestimates hypertensive side effects in patients with glioma treated with Bevacizumab

artículo científico publicado en 2015

Autoimmune diseases and immunosuppressive therapy in relation to the risk of glioma

artículo científico publicado en 2019

Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial

artículo científico publicado en 2016

CBIO-18ISOLATION OF HUMAN BRAIN TUMOUR INITIATING CELLS LEADING INVASION IN AN IN SITU ORGANOTYPIC SLICE CULTURE MIGRATION MODEL.

artículo científico publicado en 2015

CBIO-19IBUPROFEN AND DICLOFENAC INHIBIT MIGRATION AND PROLIFERATION OF HUMAN GLIOMA CELL LINES IN VITRO.

artículo científico publicado en 2015

CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles

artículo científico publicado en 2007

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

artículo científico publicado en 2014

Cloning and characterization of the expression pattern of a novel splice product MIA (splice) of malignant melanoma-derived growth-inhibiting activity (MIA/CD-RAP) [corrected]

artículo científico publicado en 2002

Combined Modulation of Tumor Metabolism by Metformin and Diclofenac in Glioma

scholarly article by Valeria Gerthofer published in August 2018

Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial

artículo científico publicado en 2016

Complete response after treatment with a somatostatin analogue in an adult patient with recurrent medulloblastoma

artículo científico publicado en 2007

Concerning: Devuyst G, Bogousslavsky I. Cholesterol and risk of cerebrovascular accidant: a role for statins?

artículo científico publicado en 2000

Correction: Lactate-Modulated Induction of THBS-1 Activates Transforming Growth Factor (TGF)-beta2 and Migration of Glioma Cells In Vitro.

artículo científico publicado en 2014

Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients

artículo científico publicado en 2015

Diabetes, use of antidiabetic drugs, and the risk of glioma

artículo científico publicado en 2016

Diabetes, use of metformin, and the risk of meningioma

artículo científico

Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET.

artículo científico publicado en 2014

Diclofenac inhibits lactate formation and efficiently counteracts local immune suppression in a murine glioma model

artículo científico publicado en 2012

Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers

artículo científico publicado en 2004

Drug Repurposing of Metabolic Agents in Malignant Glioma

scientific article published in 2018

EORTC study 26041-22041: phase I/II study on concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) with PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastoma

artículo científico publicado en 2009

Early postoperative tumor progression predicts clinical outcome in glioblastoma-implication for clinical trials

artículo científico publicado en 2017

Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II study

artículo científico publicado en 2008

Efficacy of D,L-methadone in the treatment of glioblastoma in vitro

artículo científico publicado en 2018

Efficacy of clinically relevant temozolomide dosing schemes in glioblastoma cancer stem cell lines

artículo científico publicado en 2012

Epileptic Activity Increases Cerebral Amino Acid Transport Assessed by 18F-Fluoroethyl-l-Tyrosine Amino Acid PET: A Potential Brain Tumor Mimic

artículo científico publicado en 2016

Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma

artículo científico publicado en 2004

Extent of Resection in Newly Diagnosed Glioblastoma: Impact of a Specialized Neuro-Oncology Care Center

artículo científico publicado en 2017

HOUT-06. TTFIELDS FOR NEWLY DIAGNOSED GLIOBLASTOMA: IMPACT OF CONSULTATION STRATEGY

artículo científico publicado en 2017

Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

artículo científico publicado en 2016

High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial

artículo científico publicado en 2016

High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study).

artículo científico publicado en 2016

High-grade glioma: refined diagnostics steering stratified therapy

artículo científico publicado en 2013

How do patients with primary brain tumours die? ⬇️

artículo científico publicado el 1 de septiembre de 2003

Ibuprofen and Diclofenac Restrict Migration and Proliferation of Human Glioma Cells by Distinct Molecular Mechanisms

artículo científico publicado en 2015

Imaging Biomarkers for Adult Medulloblastomas: Genetic Entities May Be Identified by Their MR Imaging Radiophenotype.

artículo científico

Information needs and requirements in patients with brain tumours and their relatives.

artículo científico publicado en 2018

Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies

artículo científico publicado en 2007

Inhibition of immunosuppressive effects of melanoma-inhibiting activity (MIA) by antisense techniques

artículo científico publicado en 2005

Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

artículo científico publicado en 2017

Intracerebral and intrathecal infusion of the TGF-beta 2-specific antisense phosphorothioate oligonucleotide AP 12009 in rabbits and primates: toxicology and safety

artículo científico publicado en 2005

Intravital imaging of glioma border morphology reveals distinctive cellular dynamics and contribution to tumor cell invasion

artículo científico publicado en 2019

Inventory of a Neurological Intensive Care Unit: Who Is Treated and How Long?

artículo científico publicado en 2015

Isolated metastasis of an EGFR-L858R-mutated NSCLC of the meninges: the potential impact of CXCL12/CXCR4 axis in EGFRmut NSCLC in diagnosis, follow-up and treatment.

artículo científico publicado en 2018

Lactate promotes glioma migration by TGF-beta2-dependent regulation of matrix metalloproteinase-2.

artículo científico publicado en 2008

Lactate-modulated induction of THBS-1 activates transforming growth factor (TGF)-beta2 and migration of glioma cells in vitro

artículo científico publicado en 2013

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial

scientific article published on 14 February 2019

Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide

artículo científico publicado en 2016

MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial

artículo científico publicado en 2015

MGMT gene silencing and benefit from temozolomide in glioblastoma

artículo científico publicado en 2005

MGMT methylation status: the advent of stratified therapy in glioblastoma?

artículo científico publicado en 2007

Maintenance therapy with 13-cis retinoid acid in high-grade glioma at complete response after first-line multimodal therapy--a phase-II study

artículo científico publicado en 2004

Melanoma-inhibiting activity (MIA/CD-RAP) is expressed in a variety of malignant tumors of mainly neuroectodermal origin

artículo científico publicado en 2002

Metabolic syndrome in relation to risk of meningioma

artículo científico publicado en 2016

Metastatic medulloblastoma in adults: outcome of patients treated according to the HIT2000 protocol

artículo científico publicado en 2015

Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-β2.

artículo científico publicado en 2016

Molecular dissection of the valproic acid effects on glioma cells

artículo científico publicado en 2016

Multicenter pilot study of radio-chemotherapy as first-line treatment for adults with medulloblastoma (NOA-07).

artículo científico publicado en 2017

NI-37INCREASED CEREBRAL AMINO ACID UPTAKE DURING AND AFTER EPILEPTIC DISORDERS MIMICS BRAIN TUMOR IN 18F-FET PET.

artículo científico publicado en 2014

NIMG-40MRI TUMOR PROGRESSION PATTERNS IN THE GLARIUS TRIAL.

artículo científico publicado en 2015

NIMG-41MRI FINDINGS IN THE GLARIUS TRIAL: PROGNOSTIC AND PREDICTIVE IMPLICATIONS.

artículo científico publicado en 2015

New aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cells

artículo científico publicado en 2013

New developments in the neuro-oncology

artículo científico publicado en 2013

Non-Invasive Prediction of IDH Mutation in Patients with Glioma WHO II/III/IV Based on F-18-FET PET-Guided In Vivo 1H-Magnetic Resonance Spectroscopy and Machine Learning

artículo científico publicado en 2020

O10.04THE RANDOMIZED, MULTICENTER GLARIUS TRIAL INVESTIGATING BEVACIZUMAB/IRINOTECAN VS STANDARD TEMOZOLOMIDE IN NEWLY DIAGNOSED, MGMT-NON-METHYLATED GLIOBLASTOMA PATIENTS: FINAL SURVIVAL RESULTS AND QUALITY OF LIFE.

artículo científico publicado en 2014

OS02.1 Multicenter pilot study of radio-chemotherapy as first-line treatment for adults with medulloblastoma - the NOA-07 trial.

artículo científico publicado en 2017

OS06.3 Characterisation of human brain tumour initiating cells leading invasion.

artículo científico publicado en 2017

OS7.7 Feasibility and toxicity of concomitant radiochemotherapy with vincristine in adult patients with medulloblastoma - results from the NOA-07 trial.

artículo científico publicado en 2016

P01.11ATF4 AS A MEDIATOR OF RESISTANCE TO TARGETED THERAPY IN HIGH-GRADE GLIOMAS.

artículo científico publicado en 2014

P01.37 Impact of C/EBPβ isoforms on brain tumor initiating cells.

artículo científico publicado en 2017

P03.02IN SITU ORGANOTYPIC SLICE CULTURE MIGRATION MODEL TO DISSECT INFILTRATIVE FROM STATIONARY HUMAN BRAIN TUMOR INITIATING CELLS.

artículo científico publicado en 2014

P09.20 Effect of age on outcome in the GLARIUS trial.

artículo científico publicado en 2017

P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines

artículo científico publicado en 2016

P16.11 Complete resection is not associated with improved survival in MGMT non-methylated glioblastoma. Results from the GLARIUS trial.

artículo científico publicado en 2017

P17.39TURN OLD INTO NEW: METFORMIN AS ANTINEOPLASTIC AGENT IN GLIOBLASTOMA.

artículo científico publicado en 2014

P17.89EFFECTS OF GLIOBLASTOMA FIRST-LINE TRIALS ON TIME DELAY TO INITIATION OF TREATMENT, SIGNS OF EARLY TUMOR PROGRESSION AND PROGRESSION-FREE SURVIVAL.

artículo científico publicado en 2014

Pegylated liposomal doxorubicin in recurrent malignant glioma: analysis of a case series

artículo científico publicado en 2007

Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma

artículo científico publicado en 2004

Pegylated-liposomal doxorubicin and oral topotecan in eight children with relapsed high-grade malignant brain tumors

artículo científico publicado en 2007

Polyarteritis nodosa complicating multiple myeloma - a case report and review of the literature

artículo científico

Procarbazine--a traditional drug in the treatment of malignant gliomas

artículo científico publicado en 2008

Prognostic relevance of miRNA-155 methylation in anaplastic glioma

artículo científico publicado en 2016

QL-13QUALITY OF LIFE AND COGNITIVE FUNCTIONING IN THE RANDOMIZED, MULTICENTER GLARIUS TRIAL INVESTIGATING BEVACIZUMAB/IRINOTECAN VS STANDARD TEMOZOLOMIDE IN NEWLY DIAGNOSED, MGMT-NON-METHYLATED GLIOBLASTOMA PATIENTS.

artículo científico publicado en 2014

Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma

artículo científico publicado en 2017

Quantitative and qualitative analysis of study-related patient information sheets in randomised neuro-oncology phase III-trials

artículo científico publicado en 2013

RARE-10. MULTICENTER PILOT STUDY OF RADIO-CHEMOTHERAPY AS FIRST-LINE TREATMENT FOR ADULTS WITH MEDULLOBLASTOMA – THE NOA-07 TRIAL

RNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma--a phase II study

artículo científico publicado en 2009

ROC analysis as an additional method to characterize time to event data

artículo científico publicado en 2005

Rechallenge with temozolomide in patients with recurrent gliomas

artículo científico publicado en 2009

Refined brain tumor diagnostics and stratified therapies: the requirement for a multidisciplinary approach

artículo científico publicado en 2013

Reply to Lu: Connecting the dots between metformin and high-grade glioma

scientific article published on 15 January 2019

Response-predictive gene expression profiling of glioma progenitor cells in vitro

artículo científico publicado en 2014

SURG-01. COMPLETE RESECTION IS NOT ASSOCIATED WITH IMPROVED SURVIVAL IN MGMT NON-METHYLATED GLIOBLASTOMA: RESULTS FROM THE GLARIUS TRIAL

SURG-27COMPLETE RESECTION OF CONTRAST ENHANCING TUMOR VOLUME IS ASSOCIATED WITH IMPROVED SURVIVAL IN RECURRENT GLIOBLASTOMA - RESULTS FROM THE DIRECTOR TRIAL.

artículo científico publicado en 2015

Salvage therapy in patients with glioblastoma: is there any benefit?

artículo científico publicado en 2003

Single-institution cross-sectional study to evaluate need for information and need for referral to psychooncology care in association with depression in brain tumor patients and their family caregivers

scientific article published on 10 September 2020

Statin use and risk of glioma: population-based case-control analysis.

artículo científico publicado en 2016

Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation

artículo científico publicado en 2016

Stem cell metabolic and spectroscopic profiling

artículo científico

Sunitinib Malate plus Lomustine for Patients with Temozolomide-refractory Recurrent Anaplastic or Low-grade Glioma

artículo científico publicado en 2015

TGF-ß isoforms in cancer: Immunohistochemical expression and Smad-pathway-activity-analysis in thirteen major tumor types with a critical appraisal of antibody specificity and immunohistochemistry assay validity

artículo científico publicado en 2015

TGF-β2 signaling in high-grade gliomas

artículo científico publicado en 2011

Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb study

artículo científico publicado en 2010

Targeted tumor therapy with the TGF-beta 2 antisense compound AP 12009.

artículo científico publicado en 2005

Temozolomide and 13-cis retinoic acid in patients with anaplastic gliomas: a prospective single-arm monocentric phase-II study (RNOP-05).

artículo científico publicado en 2011

Temozolomide preferentially depletes cancer stem cells in glioblastoma

artículo científico publicado en 2008

Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas

artículo científico publicado en 2005

The Neuroradiological Spectra of Adult and Pediatric Medulloblastoma Differ : Results from a Literature-based Meta-analysis

artículo científico publicado en 2016

The Role of Translocator Protein TSPO in Hallmarks of Glioblastoma

artículo científico publicado en 2020

The cancer stem cell subtype determines immune infiltration of glioblastoma

artículo científico publicado en 2012

Transcranial electro-hyperthermia combined with alkylating chemotherapy in patients with relapsed high-grade gliomas: phase I clinical results

artículo científico publicado en 2009

Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study

artículo científico publicado en 2012

Treatment of malignant gliomas with TGF-beta2 antisense oligonucleotides

artículo científico publicado en 2009

Tumor Cell Invasion in Glioblastoma

scientific article published on 12 March 2020

Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial

artículo científico publicado en 2018

Ultrasonic contrast agents in transcranial perfusion sonography (TPS) for follow-up of patients with high grade gliomas

artículo científico publicado en 2007

Use of Selective Cyclooxygenase-2 Inhibitors, Other Analgesics, and Risk of Glioma

artículo científico publicado en 2016

Use of cardiac glycosides and risk of glioma

artículo científico publicado en 2015

Use of metformin and outcome of patients with newly diagnosed glioblastoma: Pooled analysis

scientific article published on 29 April 2019

Use of metformin and survival of patients with high-grade glioma

scientific article published on 26 October 2018

Use of statins or NSAIDs and survival of patients with high-grade glioma

artículo científico publicado en 2018

Validation Study: Response-Predictive Gene Expression Profiling of Glioma Progenitor Cells In Vitro

artículo científico publicado en 2016

Versican isoform V1 regulates proliferation and migration in high-grade gliomas.

artículo científico publicado en 2014

[Indications and outcome of ventilated patients treated in a neurological intensive care unit]

artículo científico publicado en 2012

[Personalized therapy for gliomas].

artículo científico publicado en 2015

Lista de obras de Peter Hau

1H-nuclear magnetic resonance spectroscopy of glioblastoma cancer stem cells

ACTR-20. FINDING A PREDICTIVE MARKER FOR COMPLIANCE TO TTFIELDS THERAPY – THE COMPTUNE STUDY

ACTR-23. MOLECULAR GENETIC, HOST-DERIVED AND CLINICAL DETERMINANTS OF LONG-TERM SURVIVAL IN GLIOBLASTOMA: FIRST RESULTS FROM THE BRAIN TUMOR FUNDERS’ COLLABORATIVE CONSORTIUM

AIDS-Related Central Nervous System Toxoplasmosis With Increased 18F-Fluoroethyl-L-Tyrosine Amino Acid PET Uptake Due to LAT1/2 Expression of Inflammatory Cells.

ANGI-06. CHARACTERISATION OF INVASION OF HUMAN BRAIN TUMOUR INITIATING CELLS IN HUMAN GLIOBLASTOMA

ATF4 contributes to autophagy and survival in sunitinib treated brain tumor initiating cells (BTICs)

Aberrant expression of c-Jun in glioblastoma by internal ribosome entry site (IRES)-mediated translational activation

Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells.

Adaptive Immune Response to and Survival Effect of Temozolomide- and Valproic Acid-induced Autophagy in Glioblastoma

Adults with CNS primitive neuroectodermal tumors/pineoblastomas: results of multimodal treatment according to the pediatric HIT 2000 protocol

Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas

Advances in the therapy of high-grade glioma at relapse: pegylated liposomal doxorubicin

Adverse event grading following CTCAE v3.0 underestimates hypertensive side effects in patients with glioma treated with Bevacizumab

Autoimmune diseases and immunosuppressive therapy in relation to the risk of glioma

Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial

CBIO-18ISOLATION OF HUMAN BRAIN TUMOUR INITIATING CELLS LEADING INVASION IN AN IN SITU ORGANOTYPIC SLICE CULTURE MIGRATION MODEL.

CBIO-19IBUPROFEN AND DICLOFENAC INHIBIT MIGRATION AND PROLIFERATION OF HUMAN GLIOMA CELL LINES IN VITRO.

CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

Cloning and characterization of the expression pattern of a novel splice product MIA (splice) of malignant melanoma-derived growth-inhibiting activity (MIA/CD-RAP) [corrected]

Combined Modulation of Tumor Metabolism by Metformin and Diclofenac in Glioma

Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial

Complete response after treatment with a somatostatin analogue in an adult patient with recurrent medulloblastoma

Concerning: Devuyst G, Bogousslavsky I. Cholesterol and risk of cerebrovascular accidant: a role for statins?

Correction: Lactate-Modulated Induction of THBS-1 Activates Transforming Growth Factor (TGF)-beta2 and Migration of Glioma Cells In Vitro.

Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients

Diabetes, use of antidiabetic drugs, and the risk of glioma

Diabetes, use of metformin, and the risk of meningioma

Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET.

Diclofenac inhibits lactate formation and efficiently counteracts local immune suppression in a murine glioma model

Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers

Drug Repurposing of Metabolic Agents in Malignant Glioma

EORTC study 26041-22041: phase I/II study on concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) with PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastoma

Early postoperative tumor progression predicts clinical outcome in glioblastoma-implication for clinical trials

Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II study

Efficacy of D,L-methadone in the treatment of glioblastoma in vitro

Efficacy of clinically relevant temozolomide dosing schemes in glioblastoma cancer stem cell lines

Epileptic Activity Increases Cerebral Amino Acid Transport Assessed by 18F-Fluoroethyl-l-Tyrosine Amino Acid PET: A Potential Brain Tumor Mimic

Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma

Extent of Resection in Newly Diagnosed Glioblastoma: Impact of a Specialized Neuro-Oncology Care Center

HOUT-06. TTFIELDS FOR NEWLY DIAGNOSED GLIOBLASTOMA: IMPACT OF CONSULTATION STRATEGY

Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial

High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study).

High-grade glioma: refined diagnostics steering stratified therapy

How do patients with primary brain tumours die? ⬇️

Ibuprofen and Diclofenac Restrict Migration and Proliferation of Human Glioma Cells by Distinct Molecular Mechanisms

Imaging Biomarkers for Adult Medulloblastomas: Genetic Entities May Be Identified by Their MR Imaging Radiophenotype.

Information needs and requirements in patients with brain tumours and their relatives.

Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies

Inhibition of immunosuppressive effects of melanoma-inhibiting activity (MIA) by antisense techniques

Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

Intracerebral and intrathecal infusion of the TGF-beta 2-specific antisense phosphorothioate oligonucleotide AP 12009 in rabbits and primates: toxicology and safety

Intravital imaging of glioma border morphology reveals distinctive cellular dynamics and contribution to tumor cell invasion

Inventory of a Neurological Intensive Care Unit: Who Is Treated and How Long?

Isolated metastasis of an EGFR-L858R-mutated NSCLC of the meninges: the potential impact of CXCL12/CXCR4 axis in EGFRmut NSCLC in diagnosis, follow-up and treatment.

Lactate promotes glioma migration by TGF-beta2-dependent regulation of matrix metalloproteinase-2.

Lactate-modulated induction of THBS-1 activates transforming growth factor (TGF)-beta2 and migration of glioma cells in vitro

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial

Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide

MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial

MGMT gene silencing and benefit from temozolomide in glioblastoma

MGMT methylation status: the advent of stratified therapy in glioblastoma?

Maintenance therapy with 13-cis retinoid acid in high-grade glioma at complete response after first-line multimodal therapy--a phase-II study

Melanoma-inhibiting activity (MIA/CD-RAP) is expressed in a variety of malignant tumors of mainly neuroectodermal origin

Metabolic syndrome in relation to risk of meningioma

Metastatic medulloblastoma in adults: outcome of patients treated according to the HIT2000 protocol

Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-β2.

Molecular dissection of the valproic acid effects on glioma cells

Multicenter pilot study of radio-chemotherapy as first-line treatment for adults with medulloblastoma (NOA-07).

NI-37INCREASED CEREBRAL AMINO ACID UPTAKE DURING AND AFTER EPILEPTIC DISORDERS MIMICS BRAIN TUMOR IN 18F-FET PET.

NIMG-40MRI TUMOR PROGRESSION PATTERNS IN THE GLARIUS TRIAL.

NIMG-41MRI FINDINGS IN THE GLARIUS TRIAL: PROGNOSTIC AND PREDICTIVE IMPLICATIONS.

New aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cells

New developments in the neuro-oncology

Non-Invasive Prediction of IDH Mutation in Patients with Glioma WHO II/III/IV Based on F-18-FET PET-Guided In Vivo 1H-Magnetic Resonance Spectroscopy and Machine Learning

O10.04THE RANDOMIZED, MULTICENTER GLARIUS TRIAL INVESTIGATING BEVACIZUMAB/IRINOTECAN VS STANDARD TEMOZOLOMIDE IN NEWLY DIAGNOSED, MGMT-NON-METHYLATED GLIOBLASTOMA PATIENTS: FINAL SURVIVAL RESULTS AND QUALITY OF LIFE.

OS02.1 Multicenter pilot study of radio-chemotherapy as first-line treatment for adults with medulloblastoma - the NOA-07 trial.

OS06.3 Characterisation of human brain tumour initiating cells leading invasion.